2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 22026-06-18NCT06055465
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosishepatocellular carcinomaRecruitingPhase 22026-03-04NCT06823375